chrisvoncsefalvay/vaers-outcomes huggingface dataset:
had swollen/tender lymph nodes in left armpit; This is a spontaneous report from a contactable consumer (Patient). A 71-year-old non-pregnant female patient received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, Lot Number: EN9581), via an unspecified route of administration, administered in left arm on 25Feb2021 at 09:45 (at the age of 71-years-old), single dose for COVID-19 immunisation. The patient medical history included allergies to Amoxicillin and Bactrim. The patient previously took first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, Lot Number: EL3249), via an unspecified route of administration, administered in left arm on 04Feb2021 at 9:45 for COVID-19 immunization. There were no concomitant medications. Patient received no other vaccine in four weeks and no other medications in two weeks prior vaccination. Patient was not diagnosed with prior vaccination. On 27Feb2021, the patient had swollen/tender lymph nodes in left armpit. Patient did not receive any treatment for event. Patient was not tested for COVID-19 post vaccination. The outcome of event was recovering.  No follow-up attempts are possible. No further information is expected.
Had shot Thurs.,1/7, 10:15 AM.  Sat., 1/9, 11:00 mild diarrhea developed. Sun.,1/10, 1:30 AM, woke up with chills, no fever, and very painful, lower abdomen cramping that lasted about 2 hours with no bowel discharge. Functioned well throughout the rest of Sunday. Mon., 1/11 awoke with migraine-is headache that lasted until mid-afternoon. Never any fever.
Child noted red/raised spot at area of vaccine. Denies pruritus/pain. PE reflects 3cm round lesion at site of vaccine. Advised monitor.
Swelling lymph node under arm into left breast and skin over ribs lasting for six days.
Parents noted twitching in left shoulder then both shoulders, with confusion and more frequent week of 07/29/2015. Parent called to notify health department. Told parent to seek immediate medical care. As of 7/30/15 parent has not taken child to MD, mother says no confusion noted. Seen by Urgent Care on 8/05/15 and referred to specialist per mother.
Patient has not received 2nd dose; This case was reported by a pharmacist via call center representative and described the occurrence of incomplete course of vaccination in a 51-year-old male patient who received Herpes zoster (Shingrix) for prophylaxis.   Previously administered products included Shingrix (received 1st dose on 9th September 2020, from batch number EG3A3 and expiry date 10th December 2021).   On an unknown date, the patient received the 2nd dose of Shingrix. On an unknown date, unknown after receiving Shingrix, the patient experienced incomplete course of vaccination. On an unknown date, the outcome of the incomplete course of vaccination was unknown.  Additional details were provided as follows: The age at vaccination was not applicable for this report. The pharmacist reporting 2nd dose was greater than 6 months.  Till the time of reporting, the patient did not receive the 2nd dose, which led to incomplete course of vaccination. The reporter consented to follow up.
Patient was given an undiluted Pfizer pediatric dose today on 11/18/21 around 4:30 PM. We were in between vials, and I asked a technician to draw up more, but they didn't realize they had to dilute the vaccine before. I called the parent to let them, and I advised them on what to expect (increased flu-like symptoms). I also let them know to call if they had any questions or concerns, but as of yet they had no side effects.
chills; headache; difficulty breathing; elevated blood pressure/blood pressure shot up to 197/215; chest pain; my blood stream like a cooling effect or a chill; my arm was hurting where the injection was administered; burning sensation throughout my body; legs felt like they were on fire; This is a spontaneous report from a contactable consumer (patient) from medical information team via Pfizer Sponsored program. A 69-year-old male patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE; solution for injection, lot number, expiration date was not reported) via an unspecified route of administration, on 05Mar2021 (at the age of 69-years-old) at dose 1, single for covid-19 immunization. Medical history included stents in his legs and last 5-6 weeks (2021), he had a blockage in legs and may need amputation. The patient's concomitant medications were not reported. The patient had other unspecified vaccinations in the past and experienced chills, headache, burning sensation, difficulty breathing, elevated blood pressure and chest pain. On 05Mar2021, during vaccination, the patient could feel it enter the blood stream like a cooling effect or a chill, going through the entire body and experienced chills, headache, difficulty breathing/ breathing was heavy, elevated blood pressure/blood pressure shot up to 197/215 and chest pain, his arm was hurting where the injection was administered; it flared up about 3:30 in the morning. The patient also experienced burning sensation throughout the body, his symptoms flared up again at 3:30 in the morning and legs felt like they were on fire (as reported) on Mar2021. The patient underwent lab tests and procedures which included blood pressure measurement: 197/215 on 05Mar2021. The outcome of the event chest pain was recovered on 05Mar2021 and outcome of other events was unknown.    No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
About 5 hours after, I felt extremely tired and fatigues with mild flu like symptoms. I took a nap and when I woke up I could not move my arms or legs. It took less than 30 mins for me to be able to move again. The flu-like symptoms lasted a few days. I took some Tylenol. After 2 days, I felt back to normal.
shingles; This is a spontaneous report from a contactable healthcare professional from a Pfizer-sponsored program. A female patient of an unspecified age received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection; Batch/Lot number and Expiration date were not reported), via an unspecified route of administration on 22Mar2021 as 1st dose, single for COVID-19 immunisation. The patient's medical history and concomitant medications were not reported. The patient experienced shingles on 22Mar2021. The reporter wanted to know if it is okay for the patient to take second dose of COVID-19 vaccine after being treated for shingles with Val acyclovir medication. The reporter stated that the patient received first dose on 22Mar2021 and contracted shingles on the same day. The outcome of the event was unknown.   No follow-up attempts are needed; information about lot/batch number cannot be obtained.
Patient was given an a dose of Moderna that expired on 10/12/2021 Patient did not have any reactions to our knowledge.
Patient stated on 4/20/22 that she developed a rash on her arm three days after her pneumonia vaccination. She showed me her arm in which here was  a localized rash. She indicated she place Hydrocortisone cream on the rash. I informed her to take oral Diphenhydramine and call her primary care doctor. i said I would also call her physician. The nurse at physician's office informed patient on 4/20/22 12:30pm to take oral Benadryl and call back if symptoms not resolved in a couple days
After getting my second vaccination today I have increased ringing in both my ears. They actually have been ringing for the last 4 weeks. I got my first shot 4 weeks ago. They seemed to be a decrease in the ringing in the last few days before getting my second vaccination. But the ringing increased within an hour of getting my second shot today.  Note: about two weeks after my first shot on April 6th, I did visit my doctor because of the ringing in my ears. She was unable to determine the cause. At that time I had not connected the ringing with the vaccination. But feel that since the ringing increased within an hour of getting my second shot there is a definite connection between the vaccine and the ringing.
Elevated eye pressure; FELT WEIRD; This spontaneous case was reported by a consumer and describes the occurrence of FEELING ABNORMAL (FELT WEIRD) and INTRAOCULAR PRESSURE INCREASED (Elevated eye pressure) in a 45-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.    Co-suspect product included non-company product ADALIMUMAB (HUMIRA) solution for injection for Panuveitis.    Concurrent medical conditions included Panuveitis.   In December 2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient started ADALIMUMAB (HUMIRA) (Subcutaneous) Solution for injection in pre-filled pen, Citrate free. In December 2021, the patient experienced FEELING ABNORMAL (FELT WEIRD). On an unknown date, the patient experienced INTRAOCULAR PRESSURE INCREASED (Elevated eye pressure). At the time of the report, FEELING ABNORMAL (FELT WEIRD) had resolved and INTRAOCULAR PRESSURE INCREASED (Elevated eye pressure) was resolving.        mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was withdrawn on an unknown date.       No Concomitant medication reported. It was unknown if patient was enrolled in a COVID-19 Vaccine Trial. No Treatment medication reported.
Information has been received from a Registered nurse (R.N.) concerning a 22 year old female with no drug reactions or allergies who on 30-JUN-2010 was vaccinated with a dose of GARDASIL (Lot number 663659/1178Y) (route not reported). The nurse stated that the patient received GARDASIL and had pain at the injection site. The pain improved after a few days and then returned, became tender and progressed until patient complained that the arm was hard to lift. At the time of the report, the patient had not recovered. The patient sought unspecified medical attention. Additional information has been requested.
Extreme muscle soreness; This spontaneous case was reported by a consumer and describes the occurrence of MYALGIA (Extreme muscle soreness) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced MYALGIA (Extreme muscle soreness). At the time of the report, MYALGIA (Extreme muscle soreness) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medication reported  No treatment medication reported Upon in internal review on 24 May 2021, the age was corrected to unknown age
He was admitted with acute right sided pulmonary embolus and extensive left leg DVT. His vaccine second dose was mid Febrary ( I do not have the exact date). He had brief swelling in left leg a few days after vaccination that resolved. This recurred 4/3/21 and he was admitted 4/6/21.
Woke up with an itchy rash covering the abdomen and arms. Persists after 2 days.
One day post vax, the child developed a fever of 101 degrees. Two days post vax the pt vomited. Three days post vax, the pt developed generalized, red, raised welts. The welts persisted as of 8/8/00.
PT STATES HER ARM IS VERY SORE AND HAS A 2 AND 1/2 IN RAISED AREA AFTER RECEIVEING BOTH A FLU SHOT AND PNEUMONIA SHOT.  SHE IS ALSO COMPLAINGING OF A 103 DEGREEE FEVER
Pain at local injection site, followed by persistent neuropathy in left arm/shoulder for 2 months afterwards.
After receiving the vaccination the same day I was nauseous all day. The very next day my face was slightly swollen in areas where I?ve had fillers in my lips and around my lips. Three days after the vaccination I woke up with my face completely swollen one eye was swollen shut and my upper lip was extremely heave and yet icing my face the swelling went down a lot about two weeks after the vaccination I started slowly losing taste but ONLY with salty foods.
Mother noticed rash on the infants back, chest and face on 5/1/08 in the AM.  Mother called to report the symptoms questioning if due to vaccines given on 4/29/08.  Instructed to observe for changes or worsening of symptoms and instruction given to follow-up in the ER if worse or here at Child Health Clinic on 5/2/08.  Questioned if infant had been given any medication and Mother states gave Tylenol every 5 hours after vaccines given.  Mother did not show for appointment on 5/2/08 and when telephone call made to her she said she remebered that she had given rice cereal and cow's milk to the infant on the evening of 4/29/08, so maybe that was the cause of the rash.  Mother states rash did not get any worse and no other symptoms.  Infants temp 98.1.  Instructed to call if rash continues.
pt devel diarrhea-green, watery 5xday; pt well otherwise & had no temp & no illness prior or between vax;pt exp same rxn w/dose 1 of vax
Late 2nd dose; This non-serious case was reported by a pharmacist via call center representative and described the occurrence of drug dose administration interval too long in a 83-year-old male patient who received HAB (Twinrix) (batch number h3sg9, expiry date 03-JAN-2025) for prophylaxis.   Previously administered products included Twinrix (patient received twinrix first dose on 3-NOV-2022).   On 06-MAY-2023, the patient received the 2nd dose of Twinrix. On 06-MAY-2023, an unknown time after receiving Twinrix, the patient experienced drug dose administration interval too long (Verbatim: Late 2nd dose). The outcome of the drug dose administration interval too long was unknown.   This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences.   Additional Information: GSK Receipt Date: 10-MAY-2023. Afterhours Voicemail registered pharmacist called and left voicemail stating a patient who started Twinrix received their 1st dose on 3-NOV-2022 and got second dose on 6-MAY-2023, a little over 6 month mark.  They asked what to do for 3rd dose, would it be 6 months from 2nd dose or did they need to started series over.  The reporter asked would 2nd dose on May 6th be considered 1st of series. The reporter consented to follow up. The patient received 2nd dose of Twinrix, later than the recommended interval, which led to drug dose administration interval too long.
Swollen armpit after receiving second dose of Pfizer vaccine. Still have lump and no improvement.
Patient received first dose of Moderna at age 17. Vaccine only indicated for ages 18 and older. Per CDC recommendations, patient completed vaccination series with Moderna on 4/2/21. No adverse effects reported to vaccine clinic staff.
This spontaneous report as received from a nurse refers to unspecified number of patients of unknown demography. No concurrent condition, medical history or allergy/drug reactions were reported. The nurse reported that on an unspecified date, unspecified number of patients were vaccinated with improperly stored PEDVAXHIB injection (lot # K011078, expiry date: 31-MAR-2017) (dose, strength and route were not reported). No concomitant medications were reported. No adverse effects were reported. The outcome of the event was unknown. There were no product quality complaints (PQC) involved. No further information was provided. This is one of several reports received from the same reporter. Additional information has been requested.
I had elevated level. I get feedback  term but it appeared that my liver that is been stressed.; Body aches in my legs and more over back; Body aches in my legs and more over back; Body aches in my legs and more over back; Prolonged headache for about 2 weeks; Fatigue of head; Sore arm at the injection site; At my second ER visit they told me I had something called the  bell's palsy; after taking the first vaccination on 29May2021 at 2 PM, the next day patient had stage 3 hypertension; I have history of hypertension but it was under control prior to the taking vaccination."; This is a spontaneous report from a contactable consumer or other non hcp (patient). A 42-years-old male patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, Batch/Lot number was not reported), dose 1 intramuscular, administered in Arm Right on 29May2021 14:00 as (At the age of 42-years) 1ST DOSE, SINGLE DOSE for covid-19 immunisation. Medical history included hypertension. It was reported that patient had history of hypertension, but it was under control prior to the taking vaccination. Concomitant medication included hydrochlorothiazide taken at a dose of 50 mg once per day for hypertension; amlodipine taken at a dose of 5 mg once per day for High blood pressure. Patient did not take any vaccination 4 weeks prior to covid-19 vaccine. It was reported that patient have experienced side effects after taking the first covid vaccination and he visited the ER two times. Reportedly, after taking the first vaccination on 29May2021 at 2 PM, the next day patient had stage 3 hypertension. He had a prolonged headache for about 2 weeks. Patient experienced fatigue of head, body aches in his legs and more over back. He had sore arm at the injection site and at his second ER visit they said that he had something called the bell's palsy. It was reported that when he went to ER they perform blood tests and COVID test which tested negative. It was reported that he visited his doctor, primary care physician, he ran another lab and he had elevated level. He got feedback term, but it appeared that his liver that was been stressed. It was reported that patient was not treated for liver, he was only treated for the hypertension, for the headache and body ache he was taking ibuprofen over the counter, ibuprofen and the hospital prescribed for the bell's palsy, there are three different medication here valacyclovir, its 1-gram tablet and he take 3 per day. Prednisone, its 20 mg tablet 3 times per day, Erythromycin. The patient underwent lab tests and procedures which included blood test, covid-19: negative, liver function test increased: elevated level on unspecified date. Reporter seriousness for the events was Unspecified. Patient did not got his vaccination card yet as he was not fully vaccinated. The outcome of events was unknown.  Follow-up attempts are needed. Information on the lot/batch number has been requested.
Received Varivax in left thigh + Prevnar in right leg. About 18-24 hrs after immunizations, pt developed an urticarial rash localized to left thigh and with 2 lesions on left buttock, varied in size. Treated with Benadryl. Hives spread to arms/legs and 1 on cheek within subsequent 24 hrs. Waxes and wanes with urticaria. Hives were faint and blotchy. Started as a wheal and flare. Examined 4/6/06. No other symptoms.
Arm swollen pain, arm motion range couldn't lift arm, heart palpation nosebleed, spit up blood clotes fallen neuropathy, cane, thrombocytopenia, nerves attacted (AFib) heart pain musle loss Gullain Bar Syndrome Patient given Pfizer shot 4/2020. Patient began 1 1/2 hour later arm swollen legs num/needle pins in feet and legs. Coughing up bloot clots, lost muscle mas, weakness lost balance to walk, headaches, nauseous at stomach couldn't sleep heart paltation! Nosebleeds, arm range motion lost! Nerves attacted. Muscle mass lost, weight gain Brain to go blood clots in legs. Long Covid. Taste gone. Shots 4/16/21 Eye Sight low Pfizer Lot ER8732 5/07/21 Pfizer Lot EW0179 01/18/22 Pfizer Lot FD7218 7/04/22 PFR-BNT 30mcg/0.3mL Lot FM0173 11/15/22 Pfizer Bivalent 30mcg/0.3mL Lot GJ3277 Uptic Neuritis-Pain in eyes. I have Thrombocytopenia
9 days after vaccine, I had a miscarriage. I was 5 weeks pregnant at that time. I had confirmation lab test 2 weeks prior of pregnancy and had labs with bhcg lower at time of bleeding to confirm miscarriage
Patient got previous dose of the Moderna vaccine on 15FEB2021. Caller also asked about whether or not to start the series over again because it's 6 months out from the first vaccine; Patient got previous dose of the Moderna vaccine on 15FEB2021. Caller also asked about whether or not to start the series over again because it's 6 months out from the first vaccine; No Adverse Event; This spontaneous case was reported by an other health care professional and describes the occurrence of PRODUCT AVAILABILITY ISSUE (Patient got previous dose of the Moderna vaccine on 15FEB2021. Caller also asked about whether or not to start the series over again because it's 6 months out from the first vaccine), PRODUCT ADMINISTRATION INTERRUPTED (Patient got previous dose of the Moderna vaccine on 15FEB2021. Caller also asked about whether or not to start the series over again because it's 6 months out from the first vaccine) and NO ADVERSE EVENT (No Adverse Event) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 prophylaxis.     No Medical History information was reported.    On 15-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced PRODUCT AVAILABILITY ISSUE (Patient got previous dose of the Moderna vaccine on 15FEB2021. Caller also asked about whether or not to start the series over again because it's 6 months out from the first vaccine), PRODUCT ADMINISTRATION INTERRUPTED (Patient got previous dose of the Moderna vaccine on 15FEB2021. Caller also asked about whether or not to start the series over again because it's 6 months out from the first vaccine) and NO ADVERSE EVENT (No Adverse Event). At the time of the report, PRODUCT AVAILABILITY ISSUE (Patient got previous dose of the Moderna vaccine on 15FEB2021. Caller also asked about whether or not to start the series over again because it's 6 months out from the first vaccine), PRODUCT ADMINISTRATION INTERRUPTED (Patient got previous dose of the Moderna vaccine on 15FEB2021. Caller also asked about whether or not to start the series over again because it's 6 months out from the first vaccine) and NO ADVERSE EVENT (No Adverse Event) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter considered NO ADVERSE EVENT (No Adverse Event) to be not related. No further causality assessments were provided for PRODUCT AVAILABILITY ISSUE (Patient got previous dose of the Moderna vaccine on 15FEB2021. Caller also asked about whether or not to start the series over again because it's 6 months out from the first vaccine) and PRODUCT ADMINISTRATION INTERRUPTED (Patient got previous dose of the Moderna vaccine on 15FEB2021. Caller also asked about whether or not to start the series over again because it's 6 months out from the first vaccine).    No relevant concomitant medications were reported. No treatment medication reported.   This case was identified as part of a retrospective clean-up activity where certain emails received in the Moderna mailbox were missed to be booked-in.
Dizziness and weakness, Shortness of breath, chest pain, and mild headache. The dizziness started around 2:00 pm on September 30th and around 3 PM the same day the weakness, shortness of breath, chest pains, and mild headache started.  I did take Acetaminophen at 3:30 PM for pain and the headache started to go away a little around 4 PM. The other symptoms are still present.  I have called my primary care physician and am waiting on her response back.
patient complained of throat feels "funny or burning" APRN called. Epipen is readily at patient side. Patient is verbally speaking appropriately. Neuro + respiratory exam normal. Son is called to be with patient. Denies symptoms of anaphylaxis confirmed NKA. Patient given Diphenhydramine 50 mg + Famotidine 10mg by oral route. Recommend no work today. Advised to call 911 with red flags. Advised to call health department or PCP for any other new symptoms. Patient states she feels "fine" Patient is monitored + stable.
Patient had COVID vaccines on 3/16/21, and 4/13/21, and was admitted to inpatient at Hospital for respiratory failure due to COVID